72
Views
16
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Mean platelet volume, an indicator of platelet activation, is increased in patients with mitral stenosis and sinus rhythm

, , &
Pages 708-712 | Received 26 Dec 2008, Accepted 26 Apr 2009, Published online: 25 Nov 2009

References

  • Wolf PA, Dawber TT, Thomas HE, JrKannel WB. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: Framingham Study. Neurology. 1978; 28:973–7.
  • Kunishima S, Hattor M, Kobayashi S, Hattori H, Iwama Y, Imai Y, Ogawa K, Naoe T, Ohno R. Activation and destruction of platelets in patients with rheumatic heart disease. Eur Heart J. 1994; 15:335–8.
  • Steele PP, Weily HS, Davies H, Genton E. Platelet survival in patients with rheumatic heart disease. N Engl J Med. 1974; 290:537–9.
  • Zaki A, Salama M, Masry ME, Abou-Freikha M, Abou-Ammo D, Sweelum M, Mashhour E, Elhendy A. Immediate effect of balloon valvuloplasty on hemostatic changes in mitral stenosis. Am J Cardiol. 2000; 85:370–5.
  • Chen MC, Chang HW, Juang SS, Yip HK, Wu CJ. Increased plasma levels of soluble P-selectin in rheumatic mitral stenosis. Chest. 2004; 126:54–8.
  • Chen MC, Wu CJ, Yip HK, Chang HW, Fang CY, Yu TH, Fu M. Left atrial platelet activity with rheumatic mitral stenosis: correlation study of severity and platelet P-selectin expression by flow cytometry. Chest. 2003; 124:1663–9.
  • Topaloglu S, Boyaci A, Ayaz S, Yilmaz S, Yanik O, Ozdemir O, Soylu M, Demir AD, Aras D, Kisacik HL, Korkmaz S. Coagulation, fibrinolytic system activation and endothelial dysfunction in patients with mitral stenosis and sinus rhythm. Angiology. 2007; 58:85–91.
  • Boyaci A, Topaloglu S, Yilmaz S, Yanik O, Ozdemir O, Demir AD, Aras D, Kisacik H, Korkmaz S. Regional left atrial coagulation and fibrinolytic activities in patients with mitral stenosis. Jpn Heart J. 2004; 45:779–88.
  • Tengiz I, Ercan E, Sahin F, Alioglu E, Duman C, Saydam G, Buyukkececi F. Presence of factors that activate platelet aggregation in mitral stenotic patients’ plasma. Curr Control Trials Cardiovasc Med. 2005; 6:2–.
  • Smith RL, Blick EF, Coalson J, Stein PD. Thrombus production by turbulence. J Appl Physiol. 1972; 32:261–4.
  • Stein PD, Sabbah HN. Measured turbulence and its effect on thrombus formation. Circ Res. 1974; 35:608–14.
  • Stein PD, Sabbah HN. Turbulence blood flow in the ascending aorta of humans with normal and diseased aortic valves. Circ Res. 1976; 39:58–65.
  • Yu SK, Latour JG, Marchandise B, Bois B. Shear stressinduced changes in platelet reactivity. Thromb Haemost. 1978; 40:551–60.
  • Park Y, Schoene N, Haris W. Mean platelet volume as an indicator of platelet activation: methodological issues. Platelets. 2002; 13:301–6.
  • Boos CJ, Lip GY. Assessment of mean platelet volume in coronary artery disease – what does it mean?. Thromb Res. 2007; 120:11–3.
  • Martin JF, Trowbridge EA, Salmon GL, Plumb J. The biological significance of platelet volume: its relationship to bleeding time, platelet thromboxane B2 production and megakaryocyte nuclear DNA concentration. Thromb Res. 1983; 32:443–60.
  • Jakubowski JA, Thompson CB, Vaillancourt R, Valeri CR, Deykin D. Arachidonic acid metabolism by platelets of differing size. Br J Haematol. 1983; 5:503–11.
  • Giles H, Smith REA, Martin JF. Platelet glycoprotein IIb–IIIa and size are increased in acute myocardial infarction. Eur J Clin Invest. 1994; 24:69–72.
  • Alyan O, Metin F, Kacmaz F, Ozdemir O, Maden O, Topaloglu S, Demir AD, Karahan Z, Karadede A, Ilkay E. High levels of high sensitivity C-reactive protein predict the progression of chronic rheumatic mitral stenosis. J Thromb Thrombolysis. 2008; :–.12 July [Epub ahead of print]
  • Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978; 58:1072–83.
  • Hatle L, Angelsen B, Tromsdal A. Noninvasive assessment of atrioventricular pressure half-time by Doppler ultrasound. Circulation. 1979; 60:1096–104.
  • Atak R, Yetkin E, Yetkin O, Ayaz S, Ileri M, Senen K, Turhan H, Erbay AR, Cehreli S. Increased systemic and regional coagulation activity in patients with mitral stenosis and sinus rhythm. Angiology. 2003; 54:593–7.
  • Ileri M, Buyukasik Y, Ileri NS, Haznedaroglu IC, Goksel S, Kirazli S, Dundar S. Activation of blood coagulation in patients with mitral stenosis and sinus rhythm. Am J Cardiol. 1998; 81:795–7.
  • Chen MC, Wu CJ, Chang HW, Yip HK, Chen YH, Cheng CI, Chai HT. Mechanism of reducing platelet activity by percutaneous transluminal mitral valvuloplasty in patients with rheumatic mitral stenosis. Chest. 2004; 125:1629–34.
  • Kario K, Matsuo T, Nakao K. Cigarette smoking increases the mean platelet volume in elderly patients with risk factors for atherosclerosis. Clin Lab Haematol. 1992; 14:281–7.
  • Papanas N, Symeonidis G, Maltezos E, Mavridis G, Karavageli E, Vosnakidis T, Lakasas G. Mean platelet volume in patients with type 2 diabetes mellitus. Platelets. 2004; 15:475–8.
  • Coban E, Ozdogan M, Yazicioglu G, Akcit F. The mean platelet volume in patients with obesity. Int J Clin Pract. 2005; 59:981–2.
  • Nadar S, Blann AD, Lip GY. Platelet morphology and plasma indices of platelet activation in essential hypertension: effects of amlodipine-based antihypertensive therapy. Ann Med. 2004; 36:552–7.
  • Pathansali R, Smith N, Bath P. Altered megakaryocyte–platelet haemostatic axis in hypercholesterolaemia. Platelets. 2001; 12:292–7.
  • Debili N, Masse JM, Katz A, Guichard J, Breton-Gorius J, Vainchenker W. Effects of the recombinant hematopoietic growth factors interleukin-3, interleukin-6, stem cell factor, and leukemia inhibitory factor on the megakaryocytic differentiation of CD34ş cells. Blood. 1993; 82:84–95.
  • Burstein SA, Downs T, Friese P, Lynam S, Anderson S, Henthorn J, Epstein RB, Savage K. Thrombocytopoiesis in normal and sublethally irradiated dogs: response to human interleukin-6. Blood. 1992; 80:420–8.
  • Brown AS, Hong Y, de Belder A, Beacon H, Beeso J, Sherwood R, Edmonds M, Martin JF, Erusalimsky JD. Megakaryocyte ploidy and platelet changes in human diabetes and atherosclerosis. Arterioscler Thromb Vasc Biol. 1997; 17:802–7.
  • Chang CJ, Hsu LA, Chiang CW, Ko YS, See LC, Shen YC, Ko YL, Kou CT, Lee YS, Pang JH. Percutaneous transvenous mitral valvulotomy normalizes elevated circulating levels of tumor necrosis factor-alpha and interleukin-6 in mitral stenosis with heart failure. Am J Cardiol. 2003; 91:1018–20.
  • Trikas A, Papathanasiou S, Tousoulis D, Tentolouris K, Vasiliadou K, Antoniades C, Latsios G, Stefanadis C. Left atrial function, cytokines and soluble apoptotic markers in mitral stenosis: effects of valvular replacement. Int J Cardiol. 2005; 99:111–5.
  • Bath PM, Butterworth RJ. Platelet size: measurement, physiology and vascular disease. Blood Coagul Fibrinolysis. 1996; 7:157–61.
  • Endler G, Klimesch A, Sunder-Plassmann H, Schillinger M, Exner M, Mannhalter C, Jordanova N, Christ G, Thalhammer R, Huber K, Sunder-Plassmann R. Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol. 2002; 117:399–404.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.